NCT06776146View on ClinicalTrials.gov

Proteomic Profiling to Differentiate Pancreatic and Biliary Adenocarcinomas

Not yet recruitingOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Pancreatic Adenocarcinoma
Interventions
DIAGNOSTIC_TEST

proteomic profiling

proteomic profiling

Trial Locations (1)

Unknown

CHU Bordeaux, Pessac

All Listed Sponsors
collaborator

University of Bordeaux

OTHER

lead

University Hospital, Bordeaux

OTHER

NCT06776146 - Proteomic Profiling to Differentiate Pancreatic and Biliary Adenocarcinomas | Biotech Hunter | Biotech Hunter